Metabolic therapy for post-vaccine fatigue syndrome
Part of Immune system & allergy clinical trials.
This trial tests a treatment that targets metabolism to help people with long-term fatigue that started within two weeks of a COVID-19 vaccine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Fatigue that has lasted more than 6 months
- Got at least one COVID-19 vaccine and felt fatigue start within 2 weeks after
- A blood test showing spike protein is still present or you have spike antibodies but no history of natural COVID-19 infection
- Not pregnant
- No history of schizophrenia
- Not taking antidepressants
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who developed new, long-lasting symptoms after a COVID-19 vaccine. It aims to understand their symptoms, do lab tests, and see how they recover over time.
This trial studies whether a yoga program (compared with health education) can reduce persistent tiredness after COVID-19. It may help if your fatigue has lasted at least 12 weeks and you think it started with COVID.
This trial tests a non-invasive brain stimulation method called Transcranial Pulse Stimulation (TPS) to see if it can help people with lingering post-COVID symptoms like fatigue and brain fog. If you've had COVID-19 and still have symptoms for at least 12 months, this study might be an option for you.
This trial is testing treatments for people with long COVID, which is when symptoms last more than 3 months after a COVID-19 infection. The trial focuses on three specific symptom groups: heart inflammation, cough, or severe fatigue with signs of inflammation. It aims to find if certain immune-modulating therapies can help.
This study tests whether improving diet quality can reduce fatigue and symptoms in people with long-COVID (post-acute COVID-19 syndrome). It may help if your diet quality is currently low and your fatigue is moderate to severe.
This study tests the antidepressant fluvoxamine to see if it can reduce long-term fatigue in adults who developed severe tiredness after a covid-19 infection. You may join if your fatigue started or got worse after covid and has lasted at least 3 months.
Hear when a new Vaccine Adverse Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.